Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Post-Market Study to Assess Outcomes of Patients Treated With the AFX System Compared to Other EVAR Devices for Endovascular Abdominal Aortic Aneurysm Repair: LEOPARD

NCT02407457 is registered in ClinicalTrials.gov with Endologix as lead sponsor.

NCT NCT02407457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02407457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Post-Market Study to Assess Outcomes of Patients Treated With the AFX System Compared to Other EVAR Devices for Endovascular Abdominal Aortic Aneurysm Repair: LEOPARD
Lead sponsor
Endologix
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2015
Completion date
October 31, 2022
Enrollment
455 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal aortic aneurysm